Lipoprotein Metabolism, Dyslipidemia, and Lipid-Lowering Therapy in Women: A Comprehensive Review

被引:5
作者
Zimodro, Jakub Michal [1 ]
Mucha, Magda [2 ]
Berthold, Heiner K. [3 ]
Gouni-Berthold, Ioanna [4 ]
机构
[1] Med Univ Warsaw, Chair & Dept Cardiol 1, PL-02097 Warsaw, Poland
[2] Med Univ Bialystok, Fac Med, PL-15089 Bialystok, Poland
[3] Bethel Clin EvKB, Dept Internal Med & Geriatr, D-33611 Bielefeld, Germany
[4] Univ Cologne, Univ Hosp Cologne, Fac Med, Ctr Endocrinol Diabet & Prevent Med, Kerpener Str 62, D-50937 Cologne, Germany
关键词
atherosclerotic cardiovascular disease; cholesterol; dyslipidemia; lipid-lowering therapy; women; sex differences; HORMONE REPLACEMENT THERAPY; ALPHA GENE VARIATION; SEX-DIFFERENCES; ESTROGEN-RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; CARDIOVASCULAR-DISEASE; SCAVENGER RECEPTOR; GENDER-DIFFERENCES; MENSTRUAL-CYCLE; LDL-CHOLESTEROL;
D O I
10.3390/ph17070913
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Lipid-lowering therapy (LLT) is a cornerstone of atherosclerotic cardiovascular disease prevention. Although LLT might lead to different reductions in low-density lipoprotein cholesterol (LDL-C) levels in women and men, LLT diminishes cardiovascular risk equally effectively in both sexes. Despite similar LLT efficacy, the use of high-intensity statins, ezetimibe, and proprotein convertase subtilisin/kexin type 9 inhibitors is lower in women compared to men. Women achieve the guideline-recommended LDL-C levels less often than men. Greater cholesterol burden is particularly prominent in women with familial hypercholesterolemia. In clinical practice, women and men with dyslipidemia present with different cardiovascular risk profiles and disease manifestations. The concentrations of LDL-C, lipoprotein(a), and other blood lipids differ between women and men over a lifetime. Dissimilar levels of LLT target molecules partially result from sex-specific hormonal and genetic determinants of lipoprotein metabolism. Hence, to evaluate a potential need for sex-specific LLT, this comprehensive review (i) describes the impact of sex on lipoprotein metabolism and lipid profile, (ii) highlights sex differences in cardiovascular risk among patients with dyslipidemia, (iii) presents recent, up-to-date clinical trial and real-world data on LLT efficacy and safety in women, and (iv) discusses the diverse medical needs of women and men with dyslipidemia and increased cardiovascular risk.
引用
收藏
页数:23
相关论文
共 182 条
[1]   Response by sex to statin plus ezetimibe or statin monotherapy: A pooled analysis of 22,231 hyperlipidemic patients [J].
Abramson, Beth L. ;
Benlian, Pascale ;
Hanson, Mary E. ;
Lin, Jianxin ;
Shah, Arvind ;
Tershakovec, Andrew M. .
LIPIDS IN HEALTH AND DISEASE, 2011, 10
[2]   Sex-related differences in premature cardiovascular disease in familial hypercholesterolemia [J].
Agarwala, Anandita ;
Deych, Elena ;
Jones, Laney K. ;
Sturm, Amy C. ;
Aspry, Karen ;
Ahmad, Zahid ;
Ballantyne, Christie M. ;
Goldberg, Anne C. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (01) :150-156
[3]   Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort [J].
Allard, Matthew D. ;
Saeedi, Ramesh ;
Yousefi, Masoud ;
Frohlich, Jiri .
LIPIDS IN HEALTH AND DISEASE, 2014, 13
[4]   Sex differences in the perception of cardiovascular risk in familial hypercholesterolemia [J].
Alshibani, Balaqis ;
Iatan, Iulia ;
Guerin, Amanda ;
Ruel, Isabelle ;
Cermakova, Lubomira ;
Ramanakumar, Agnihotram V. ;
Pilote, Louise ;
Coutinho, Thais ;
Brunham, Liam R. ;
Genest, Jacques .
JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (01) :e97-e104
[5]   XX sex chromosome complement promotes atherosclerosis in mice [J].
AlSiraj, Yasir ;
Chen, Xuqi ;
Thatcher, Sean E. ;
Temel, Ryan E. ;
Cai, Lei ;
Blalock, Eric ;
Katz, Wendy ;
Ali, Heba M. ;
Petriello, Michael ;
Deng, Pan ;
Morris, Andrew J. ;
Wang, Xuping ;
Lusis, Aldons J. ;
Arnold, Arthur P. ;
Reue, Karen ;
Thompson, Katherine ;
Tso, Patrick ;
Cassis, Lisa A. .
NATURE COMMUNICATIONS, 2019, 10 (1)
[6]   Lipid profile differences during menopause: a review with meta-analysis [J].
Ambikairajah, Ananthan ;
Walsh, Erin ;
Cherbuin, Nicolas .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (11) :1327-1333
[7]   Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry [J].
Amrock, Stephen M. ;
Duell, P. Barton ;
Knickelbine, Thomas ;
Martin, Seth S. ;
O'Brien, Emily C. ;
Watson, Karol E. ;
Mitri, Joanna ;
Kindt, Iris ;
Shrader, Peter ;
Baum, Seth J. ;
Hemphill, Linda C. ;
Ahmed, Catherine D. ;
Andersen, Rolf L. ;
Kullo, Iftikhar J. ;
McCann, Dervilla ;
Larry, John A. ;
Murray, Michael F. ;
Fishberg, Robert ;
Guyton, John R. ;
Wilemon, Katherine ;
Roe, Matthew T. ;
Rader, Daniel J. ;
Ballantyne, Christie M. ;
Underberg, James A. ;
Thompson, Paul ;
Duffy, Dannielle ;
Linton, MacRae F. ;
Shapiro, Michael D. ;
Moriarty, Patrick M. ;
Knowles, Joshua W. ;
Ahmad, Zahid S. .
ATHEROSCLEROSIS, 2017, 267 :19-26
[8]   The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis [J].
Anagnostis, Panagiotis ;
Galanis, Petros ;
Chatzistergiou, Vasileia ;
Stevenson, John C. ;
Godsland, Ian F. ;
Lambrinoudaki, Irene ;
Theodorou, Mamas ;
Goulis, Dimitrios G. .
MATURITAS, 2017, 99 :27-36
[9]   A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis [J].
Armstrong, Susan M. ;
Sugiyama, Michael G. ;
Fung, Karen Y. Y. ;
Gao, Yizhuo ;
Wang, Changsen ;
Levy, Andrew S. ;
Azizi, Paymon ;
Roufaiel, Mark ;
Zhu, Su-Ning ;
Neculai, Dante ;
Yin, Charles ;
Bolz, Steffen-Sebastian ;
Seidah, Nabil G. ;
Cybulsky, Myron I. ;
Heit, Bryan ;
Lee, Warren L. .
CARDIOVASCULAR RESEARCH, 2015, 108 (02) :268-277
[10]   The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport [J].
Badeau, Robert M. ;
Metso, Jari ;
Kovanen, Petri T. ;
Lee-Rueckert, Miriam ;
Tikkanen, Matti J. ;
Jauhiainen, Matti .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (04) :317-323